Physician, Investor, Venture Builder
TORONTO--(BUSINESS WIRE)--Neurable Inc., a leading developer of brain-computer interface (BCI) technology, and Healthspan Digital Inc., a Canadian HealthTech in precision health and longevity solutions, are thrilled to announce their collaboration...
Endocrinology
Genetics
Investor
Venture Builder
I am an endocrinologist and biochemical geneticist with a career dedicated to advancing precision medicine, genomics, and digital health. I serve as Managing Partner at FHS Capital and Clinical Professor at the University of British Columbia.
Earlier in my career, I led academic and clinical research programs at the National Institutes of Health (NIH), where my work focused on cortisol and growth hormone dysregulation. This research has contributed to more than 100 peer-reviewed publications, shaping global understanding of stress physiology, endocrine disorders, and their impact on human health and performance.
Today, I translate these scientific foundations into commercial innovation, helping medtech and biotech companies bridge advanced research with market-ready, scalable products that extend healthspan and optimize human potential. My investment and advisory portfolio includes Eli Health, Flyby, Science & Humans, Supernatural, AI Nexus, Jung+, and Neurable, among others, companies pioneering the convergence of technology, biology, and artificial intelligence to redefine the future of human optimization.
My mission is to build the infrastructure for longevity-focused care globally – integrating AI, multi-omics, and digital platforms to empower individuals in optimizing health and extending healthspan.
Education
2003-2009
Medical Degree, University of Jordan School of Medicine
2009-2012
Research Assistant, Vancouver General Hospital, University of British Columbia
2012-2015
Internal Medicine Residency, Yale School of Medicine
2015-2017
Fellowship in Endocrinology & Metabolism, National Institutes of Health
2017-2018
Fellowship in Clinical Biochemical Genetics, University of Toronto
2015-2019
Associate Investigator, Adrenal and Growth Hormone disorders, NICHD, NIH
2019-2021
Associate Program Director, NIH Endocrinology Fellowship Program
2019-2021
Director, Graduate Medical Education, NICHD, National Institutes of Health
2019-2021
Principal Investigator, Adrenal and Growth Hormone disorders, NICHD, NIH
2019-2022
Founding Editor-In-Chief, Endocrine and Metabolic Science (Elsevier)
2022
Assistant Clinical Professor, Department of Medicine, University of British Columbia
2024
Faculty, Geneva College of Longevity Science
ADVISORY, INVESTMENTS, VENTURES
Leaders on Purpose • YouTube
In this video, Dr. Fady Hannah-Shmouni delves into the fascinating world of longevity, uncovering essential topics that can significantly impact your health as you age.
Longevity Talk • Instagram
I’ve invested in many businesses, but I never invested in my health. Recently, I came across a clinic, “Lifespan Sports Medicine,” in Dubai, that specializes in longevity programs.
A book providing multidisciplinary guidance on transitioning young patients with genetic endocrine cancers to adult healthcare, covering diagnostics, treatment, and survivorship strategies.
A paper exploring the diagnostic approach to adrenal insufficiency through a case study of a 32-year-old woman, highlighting the role of cortisol and ACTH stimulation testing.
A set of guidelines providing comprehensive, evidence-based recommendations for preventing, diagnosing, and managing hypertension in adults and children, with new insights on resistant hypertension and hypertension in pregnancy.
A paper reassessing previous estimates, finding lower-than-reported rates in Ashkenazi Jews and Caucasians, highlighting its relevance in preconception and infertility counseling.
